Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors [PDF]
The Journal of cell biology, 1987 Blasi, F. +2 more
openaire +4 more sources
arXivWe introduce a new global sensitivity measure called global activity score. The new measure is obtained from the global active subspace method, similar to the way the activity score measure is obtained from the active subspace method. We present theoretical results on the relationship between Sobol' sensitivity indices and global activity scores.
arxiv
The Receptor for Urokinase-Type Plasminogen Activator of a Human Keratinocyte Line (HaCaT) [PDF]
, 1994 Jeannette Reinartz +3 more
openalex +1 more source
Role of soluble urokinase type plasminogen activator receptor (suPAR) in predicting mortality, readmission, length of stay and discharge in emergency patients: A systematic review and meta analysis. [PDF]
Medicine (Baltimore), 2023 Rehan ST +9 more
europepmc +1 more source
Soluble urokinase-type plasminogen activator receptor (suPAR) in multiple respiratory diseases [PDF]
, 2015 Serum soluble urokinase-type plasminogen activator receptor (suPAR) is a glycoprotein secreted during infections and inflammation [1]. Urokinase-type plasminogen activator (uPA) is secreted by polymorphonuclear neutrophils (PMN) and macrophages; then uPA
ÜMMÜGÜLSÜM CAN
core +1 more source
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Is a Biomarker Associated with Left Ventricular Hypertrophy in the Elderly, Specifically in Women. [PDF]
J Clin Med, 2023 Wlazeł RN +5 more
europepmc +1 more source
Significance of suPAR in glomerular diseases
Linchuang shenzangbing zazhi, 2020 The soluble urokinase-type plasminogen activator receptor(suPAR) is a new type of biomarkers, and can be used for a variety of diagnosis, evaluation and prognosis of many diseases.
RUAN Dong-dong, YUAN Jun
doaj
Comparison of intravenous bolus injection or continuous infusion of recombinant single chain urokinase-type plasminogen activator (saruplase) for thrombolysis. A canine model of combined coronary arterial and femoral venous thrombosis [PDF]
, 1990 HJ Rapold +4 more
openalex +1 more source
Effect of urokinase-type plasminogen activator combined with clinical stage and Barcelona Clinic Liver Cancer stage on the prognosis of patients with hepatocellular carcinoma. [PDF]
J Gastrointest Oncol, 2023 Wu J +7 more
europepmc +1 more source
Plasminogen Activation Initiated by Single-chain Urokinase-type Plasminogen Activator
, 1989 Vincent Ellis +2 more
openalex +1 more source